Skip to main content
. 2020 Sep 1;12(9):837. doi: 10.3390/pharmaceutics12090837

Table 2.

Summary of different stimuli-responsive nanocarriers.

Stimuli Type Advantages Challenges/Limitations References
Thermo-Responsive
  • Tunable drug release

  • The clearance and accumulation of NPs in off-target organs such as the liver and spleen

  • Limited to the targets with known localization

[80,83,84]
pH-Sensitive
  • Localized delivery

  • Reduced side-effects

  • Prolonged activity

  • Fast clearance

  • Specificity limited to the microenvironment

[80,86,87,88,90,91,92,93,94,95]
Ultrasound-Triggered
  • On-demand drug release

  • Enhanced drug accumulation

  • Non-invasive

  • Production of intracellular free radicals in response to ultrasound

  • Limited to the targets with known localization

[80,96,97,98]
Light-Responsive
  • Little to no leakage in the absence of a trigger

  • High efficiency in drug releasing

  • Non-sustained drug release, might require multiple administration

  • Side-effects of byproducts

  • DNA damage by UV light

  • Limited to the targets with known localization

[99,100,101]
Redox-Responsive
  • Localized delivery

  • Prompt response in cargo release

  • Quickly oxidized

  • Fast clearance

  • Specificity limited to the microenvironment

[103,105,106]
Magnetic-Targeting
  • Improved targeting efficiency

  • Energy consuming

  • Selection of the proper magnetic carrier and magnetic force

  • Low therapeutic efficacy

  • Difficult to control magnetic nanoparticle distribution and deep tissue penetration

  • Limited to the targets with known localization

[122,123,124,125,126]
Enzyme-Responsive
  • Localized delivery

  • Higher therapeutic efficacy

  • Less controllable drug release

  • Difficulty in constructing enzyme-specific substrate

[127,128,129,130,131,133]